Showing posts with label Transcatheter Mitral Valve Replacement. Show all posts
Showing posts with label Transcatheter Mitral Valve Replacement. Show all posts

Monday, 30 July 2018

Transcatheter Mitral Valve Replacement Market 2018 : Global and United States Industry Key Participants, Opportunities, Revenue, Application, Type, Regions by 2025

ResearchMoz presents professional and in-depth study of "2018-2025 Transcatheter Mitral Valve Replacement Report on Global and United States Market, Status and Forecast, by Players, Types and Applications".

This report studies the Transcatheter Mitral Valve Replacement market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Transcatheter Mitral Valve Replacement market by product type and application/end industries.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1863647

The global Transcatheter Mitral Valve Replacement market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transcatheter Mitral Valve Replacement.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Transcatheter Mitral Valve Replacement in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

View Complete TOC with tables & Figures @ https://www.researchmoz.us/2018-2025-transcatheter-mitral-valve-replacement-report-on-global-and-united-states-market-status-and-forecast-by-players-types-and-applications-report.html/toc

The major players in global and United States market, including
Abbott Laboratories
Edwards Lifesciences
Micro Interventional Devices
Neovasc
MitrAssist
NaviGate Cardiac Structures
Valtech
On the basis of product, the market is primarily split into
Transfemoral implantation
Transapical implantation
Transaortic implantation
On the basis on the end users/application, this report covers
Hospital
Clinic

 Table of Contents

1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer

2 Transcatheter Mitral Valve Replacement Market Overview
2.1 Transcatheter Mitral Valve Replacement Product Overview
2.2 Transcatheter Mitral Valve Replacement Market Segment by Type
2.2.1 Transfemoral implantation
2.2.2 Transapical implantation
2.2.3 Transaortic implantation
2.3 Global Transcatheter Mitral Valve Replacement Product Segment by Type
2.3.1 Global Transcatheter Mitral Valve Replacement Sales (K Units) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Transcatheter Mitral Valve Replacement Sales (K Units) and Market Share (%) by Type (2013-2018)
2.3.3 Global Transcatheter Mitral Valve Replacement Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Transcatheter Mitral Valve Replacement Price (USD/Unit) by Type (2013-2018)
2.4 United States Transcatheter Mitral Valve Replacement Product Segment by Type

Browse Report @ https://www.researchmoz.us/2018-2025-transcatheter-mitral-valve-replacement-report-on-global-and-united-states-market-status-and-forecast-by-players-types-and-applications-report.html

2.4.1 United States Transcatheter Mitral Valve Replacement Sales (K Units) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Transcatheter Mitral Valve Replacement Sales (K Units) and Market Share by Type (2013-2018)
2.4.3 United States Transcatheter Mitral Valve Replacement Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Transcatheter Mitral Valve Replacement Price (USD/Unit) by Type (2013-2018)

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Wednesday, 22 February 2017

Global Transcatheter Mitral Valve Replacement (TMVR) Industry : Insights, Development, Research and Forecast 2017-2021

Researchmoz added Most up-to-date research on "Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size & Forecasts (2016-2021)" to its huge collection of research reports.

The report entitled Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size, Trends & Forecasts (2016-2021), provides analysis of the global TMVR market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value, by volume, by segments and by penetration.

The report also includes the detailed analysis of the regional TMVR market of the following regions: The US and Europe. The analysis in this segment is done by penetration, by segments, by value and by volume.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global TMVR market has also been forecasted for the years 2016-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Edward Lifesciences, Medtronic and Abbott are some of the key players operating in the global TMVR market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=770185

Country Coverage
US
Europe

Company Coverage
Edward Lifesciences Corporation
Medtronic
Abbott Laboratories, Inc.

Executive Summary
The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time .

The causes of MR disease are congenital heart disorder, rheumatic fever, trauma, any other heart disease, radiation therapy, etc. The treatments available for MR disease are surgical repair, drug treatment and replacement. There are two types of MR: Degenerative MR (DMR) and Functional MR (FMR). The DMR and FMR can further be subdivided into many types.

There are different approaches for replacement surgery, depending upon the type of MR disease. The TMVR market is in very early stage at this moment, with many companies developing their TMVR devices. The commercial TMVR devices are expected to be launched in next 2-3 years.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=770185

Currently, the global TMVR market is in early stage, but is expected to increase at high growth rates during the forecasted period (2016-2021). The global TMVR market is supported by various growth drivers, such as aging population, high number of cases of congenital heart defects, rheumatic fever, low survival rate of surgical repair in FMR patients, etc. Yet, the market faces certain challenges, such as, complexity in design, success of repair surgery in DMR patients, high number of patients not referred for surgery, etc.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://mymarketresearchlifereports.blogspot.in

Sunday, 4 December 2016

Global Transcatheter Mitral Valve Replacement (TMVR) Industry : Insights, Development, Research and Forecast 2016-2021

ResearchMoz presents this most up-to-date research on Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size & Forecasts (2016-2021).

Scope :

The report entitled Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size, Trends & Forecasts (2016-2021), provides analysis of the global TMVR market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value, by volume, by segments and by penetration.

The report also includes the detailed analysis of the regional TMVR market of the following regions: The US and Europe. The analysis in this segment is done by penetration, by segments, by value and by volume.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global TMVR market has also been forecasted for the years 2016-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Edward Lifesciences, Medtronic and Abbott are some of the key players operating in the global TMVR market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=770185

Country Coverage

US
Europe

Company Coverage

Edward Lifesciences Corporation
Medtronic
Abbott Laboratories, Inc.

Executive Summary

The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time .

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG